291.57
前日終値:
$285.98
開ける:
$284.5
24時間の取引高:
1.23M
Relative Volume:
0.59
時価総額:
$65.65B
収益:
$189.25B
当期純損益:
$5.36B
株価収益率:
12.41
EPS:
23.5
ネットキャッシュフロー:
$5.34B
1週間 パフォーマンス:
+3.50%
1か月 パフォーマンス:
-23.57%
6か月 パフォーマンス:
-27.16%
1年 パフォーマンス:
-44.97%
Elevance Health Inc Stock (ELV) Company Profile
名前
Elevance Health Inc
セクター
電話
(800) 331-1476
住所
220 VIRGINIA AVENUE, INDIANAPOLIS
ELV を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ELV
Elevance Health Inc
|
291.56 | 65.10B | 189.25B | 5.36B | 5.34B | 23.50 |
![]()
UNH
Unitedhealth Group Inc
|
267.68 | 254.96B | 410.06B | 22.11B | 24.86B | 23.88 |
![]()
CI
Cigna Group
|
296.25 | 79.17B | 254.47B | 5.03B | 6.01B | 18.06 |
![]()
CVS
Cvs Health Corp
|
60.51 | 76.79B | 378.96B | 5.28B | 5.94B | 4.19 |
![]()
HUM
Humana Inc
|
235.26 | 28.72B | 117.76B | 1.21B | 2.39B | 9.95 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-21 | ダウングレード | Argus | Buy → Hold |
2025-07-18 | ダウングレード | Leerink Partners | Outperform → Market Perform |
2025-04-15 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2025-03-17 | アップグレード | Argus | Hold → Buy |
2025-01-22 | ダウングレード | Stephens | Overweight → Equal-Weight |
2024-10-18 | ダウングレード | Argus | Buy → Hold |
2024-07-18 | ダウングレード | BofA Securities | Buy → Neutral |
2024-06-24 | 開始されました | Morgan Stanley | Overweight |
2024-05-30 | 開始されました | Robert W. Baird | Outperform |
2024-03-06 | 開始されました | Barclays | Overweight |
2023-07-12 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
2023-04-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
2023-03-28 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
2022-09-09 | アップグレード | BofA Securities | Neutral → Buy |
2022-08-22 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
すべてを表示
Elevance Health Inc (ELV) 最新ニュース
Elevance Health Board Appoints Steve Collis As Director - citybiz
Elevance Health, Inc. (ELV) Downgrades 2025 Earnings Amid Rising Medical Costs - MSN
Elevance Health Board Welcomes Steve Collis as New Director, Reflecting Ongoing Commitment to Governance Excellence - The Globe and Mail
Elevance Health (ELV) Receives Buy Rating from UBS with Optimistic EPS Forecast - GuruFocus
Elevance Health, Inc: A Deeply Undervalued Long-Term OpportunityF.A.S.T. GraphsCommentaries - Advisor Perspectives
What makes Elevance Health Inc. stock price move sharplyExceptional growth trajectory - jammulinksnews.com
Indiana Chamber Ends Partnership With Anthem, Cites Negotiation Breakdown - InkFreeNews.com
Centene's First Quarterly Loss In 13 Years Sends Shares Crashing - Benzinga
Elevance Health Inc. Stock Analysis and ForecastHigh-yield trading alerts - PrintWeekIndia
Elevance Health (ELV) Analyst Rating Update: Price Target Adjusted | ELV Stock News - GuruFocus
Elevance Health (ELV) Target Price Adjusted Amid Market Concerns - GuruFocus
Elevance Health (ELV) Target Price Adjusted Amid Market Concerns | ELV Stock News - GuruFocus
Wells Fargo Cuts Elevance (ELV) Price Target on Margin Uncertainty - Yahoo Finance
Is Elevance Health Inc. stock a growth or value playConsistent high-yield stocks - jammulinksnews.com
UnitedHealth, Anthem, Cigna unveil what small employers might pay for 2026 health coverage - BenefitsPRO
Molina Healthcare Stumbles; Cigna, CVS And Humana Go With ItMolina Healthcare (NYSE:MOH) - Benzinga
Elevance Health's Strategic Acquisition of CareBridge: Accelerating Carelon's Dominance in Value-Based, Home-Based Care - AInvest
Elevance Health: CEO Buys As CareBridge Drives Strong Growth - Seeking Alpha
Elevance Health (NYSE:ELV) stock falls 14% in past week as one-year earnings and shareholder returns continue downward trend - Yahoo Finance
Is Elevance Health Inc. a good long term investmentAccelerated earnings growth - Autocar Professional
Elevance Health, Inc. (ELV): I Won’t Touch It With A 10 Foot Pole, Says Jim Cramer - MSN
What analysts say about Elevance Health Inc. stockBreakout stock performance - jammulinksnews.com
ELV DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, - GlobeNewswire
Indiana Chamber will no longer have Anthem as provider for small-business health coverage - Inside INdiana Business
Elevance Health, EchoStar, Icahn Enterprises, Evolent Health, and The Trade Desk Shares Are Soaring, What You Need To Know - TradingView
Elevance Health Named Top Dividend Stock With Insider Buying and 2.43% Yield (ELV) - Nasdaq
What drives Elevance Health Inc. stock priceSuperior investment outcomes - jammulinksnews.com
Oscar Health sees full-year loss as ACA market troubles spread - Modern Healthcare
Breakthrough: Apple Watch-Based Asthma Program Shows Major Success in Nationwide Clinical Trial - Stock Titan
Barclays Adjusts Elevance Health (ELV) Price Target After Earnin - GuruFocus
UBS Lowered Firm’s PT on Elevance Health (ELV), Kept a Buy Rating - MSN
Lobbying Update: $1,380,000 of ELEVANCE HEALTH INC. lobbying was just disclosed - Quiver Quantitative
Hedge Fund and Insider Trading News: Bill Ackman, Warren Buffett, Ken Griffin, Neville Shah, Sage Capital, Elevance Health Inc (ELV), NVIDIA Corp (NVDA), and More - Insider Monkey
Elevance Health downgraded at Argus on profit margin pressure - MSN
Elevance Health (ELV) Drops 18.66% After Dismal Q2 Earnings - MSN
Elevance Health stock hits 52-week low at 275.6 USD - Investing.com
Elevance Health (ELV) Nosedives 12% on Disappointing Q2 - MSN
Elevance Health: the big hit - MarketScreener
Gail Boudreaux Bought 6.0% More Shares In Elevance Health - simplywall.st
Elevance Health, Inc.'s (NYSE:ELV) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - Yahoo Finance
Cantor Fitzgerald Reiterates ‘Overweight’ Rating on Elevance Health (ELV) - MSN
Elevance Health, Inc. (NYSE:ELV) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny - 富途牛牛
Elevance Health Inc. (NYSE:ELV) Q2 2025 Earnings Call Transcript - MSN
Elevance Health Inc (ELV) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):